DESCRIPTION OF BLOOD SUGAR LEVELS OF DM PATIENTS WITH ORAL HYPOGLYCEMIC DRUG ADMINISTRATION AT ONE OF THE JEMBER HOSPITALS
DOI:
https://doi.org/10.36858/ipj.v1i1.8Keywords:
Diabetes mellitus, Metformin, Glimepiride, Blood sugar levelsAbstract
Background: Diabetes Mellitus (DM) is a chronic disease caused by impaired metabolism of fat, carbohydrates and proteins, characterized by high blood sugar levels that exceed normal limits. The incidence of DM will increase every year, the increasing incidence of DM can be caused by risk factors, such as obesity, physical activity and age. This study aims to determine the use of metformin and glimepiride along with a picture of blood sugar levels of diabetes mellitus patients before and after administering single metformin and glimepiride drugs at one of the hospitals in Jember. Methods: This study includes non-experimental research, namely obervasional with analytical descriptive research design with cross sectional methods. Samples were taken using a total sampling technique that met the inclusion criteria of 32 outpatients. Data were taken using observation sheets and recapitulation sheets. Research Results: The use of metformin and glimepiride drugs in type 2 DM patients in one of the hospitals in Jember is metformin as much as 15.6% while glimepiride is 84.4%. The data showed the difference in the average blood sugar levels of patients before using metformin which was 233.2 mg / dl and after using metformin which was 168.4 mg / dl and the difference in the average blood sugar levels of patients before using glimepiride was 246.7 mg / dl and after using glimepiride was 181.5 mg / dl. Conclusion: The use of metformin and glimepiride alone drugs in patients with type 2 diabetes showed that almost all patients used a single glimepiride drug which was 84.4%. Single metformin and glimepiride drugs were also able to lower blood sugar levels of type 2 diabetes patients in one of the medical record rooms of the outpatient hospital installation in Jember.
References
Amin, R. T., Martiana, I., Palupi, J., & Jamhariyah. (2022). Diabetes Mellitus, Glucose Level, Self Empowerment C. Nursing Update, 13(4), 1–11.
Anas Putri Maria Natasya Panamuan, Eka Kartika Untari, S. R. (2021). Pengaruh Usia Pasien dan Dosis terhadap Efek Samping Metformin pada Pasien Diabetes Tipe 2. Jurnal Farmasi Komunitas, 8(2), 51–58.
Defirson, & Lailan Azizah. (2021). Perbandingan efektivitas obat antidiabetik oral pada pasien diabetes mellitus tipe 2 rawat jalan di Rumah Sakit “X” Kota Jambi. Riset Informasi Kesehatan, 10(2), 134–142.
Harli, K., & Irfan. (2022). Analisis Faktor yang Berhubungan dengan Self-Awareness Keperawatan Kaki pada Pasien DM tipe 2. Jurnal Keperawatan Silampari, 6(1).
Kuna, M. R., Ananda, M., Manika, O., & Pobela, T. (2022). Analisis Penggunaan Obat Pada Pasien Diabetes Melitus di Puskesmas Gogagoman Tahun 2022. Jurnal Cakrawala Ilmiah, 2(4), 1631–1638.
Kurniawaty, E., & Yanita, B. (2016). Faktor-Faktor yang Berhubungan dengan Kejadian Diabetes Melitus Tipe II Risk Factors Related Type 2 Diabetes Mellitus Evidance. Majority, 5(2), 27–31.
Lamoia, T.E., Shulman, G.L., (2021). Cellular and Molecular Mechanisms of Metformin Action. Endocrine Reviews. 42(1), 77-96.
Irfan, I., & Israfil, I. (2020). Faktor Risiko Kejadian Komplikasi Kardiovaskuler pada Pasien Diabetes Melitus (DM) Tipe 2. Jurnal Persatuan Perawat Nasional Indonesia (JPPNI), 4(3), 162.
Malihah, D., & Emelia, R. (2020). Pola Pengobatan Antidiabetes Terhadap Pasien Diabetes Melitus Tipe II Rawat Jalan di RSAU dr.M. Salamun. Jurnal Delima Harapan 2022, 7(September), 31–38.
Mirza, M. (2020) "Gambaran Faktor Risiko Diabetes Mellitus Tipe-II Pada Pasien Poliklinik Penyakit Dalam di Rumah Sakit Meraxa Kota Banda Aceh Tahun 2018," Kandidat, 2(2), hal. 35-41.
Nyoman, N., Udayani, W., Agung, I. G., Kusuma, A., Ayu, I. D., & Yustari, A. (2022). Evaluasi Efek Samping Penggunaan Obat Kombinasi Metformin dan Glimepiride pada Pasien Diabetes Melitus Tipe 2 Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients. Jurnal Ilmiah Medicamento, 8(2), 99–103.
Panamuan &Untari, S. R. (2021). Pengaruh Usia Pasien dan Dosis terhadap Efek Samping Metformin pada Pasien Diabetes Tipe 2. Jurnal Farmasi Komunitas, 8(2), 51–58.
PERKENI, (2015). Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia. Perkeni; Jakarta PERKENI, (2019) Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2019, Perkumpulan Endokrinologi Indonesia. PB PERKENI.
PERKENI. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia.
Sasmiyanto, S. (2020). Faktor Predisposisi Perilaku Kesehatan Penderita Diabetes Mellitus Tipe 2. Jurnal Keperawatan Silampari, 3(2), 466–476.
Suryanegara, N. M., Acang, N., & Suryani, Y. D. (2021). Kajian Mengenai Komplikasi Makrovaskular pada Pasien Diabetes Melitus Tipe 2. Integrasi Kesehatan Dan Sains, 3(2), 2–4.
Tjekyan, R. (2014). Angka Kejadian dan Faktor Risiko Diabetes Melitus Tipe 2. Majalah Kedokteran Sriwijaya, 46(2), 85–94.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Khafifah Al Addawiah, Jamhariyah, Wima Anggitasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
